Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: A dose-finding study

British Journal of Cancer

Volumn 91, Issue 4, 2004, Pages 618-620

  Ficorella, C ^a   Morelli, M F ^a   Ricevuto, E ^a   Cannita, K ^a   Porzio, G ^a   Lanfiuti Baldi, P ^a   Cianci, G ^a   Di Rocco, Z C ^a   Natoli, C ^b   Tinari, N ^b   De Galitiis, F ^a   Calista, F ^a   Marchetti, P ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

5 fluorouracil; Breast cancer; Docetaxel

Indexed keywords

DOCETAXEL; FLUOROURACIL; FLUOROURACIL TEVA;

ADULT; AGED; ARTICLE; ASTHENIA; BREAST METASTASIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DOSE RESPONSE; DRUG INFUSION; DRUG MEGADOSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FLUID RETENTION; HUMAN; MUCOSA INFLAMMATION; NAIL DISEASE; NAUSEA; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SIDE EFFECT; STOMATITIS; TIME; TOXICITY; VOMITING;

EID: 4344672492     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601971     Document Type: Article

References (8)

1. Ando M, Watanabe T, Sasaki Y, Ying DF, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I, Taguchi T (1998) A phase I/II study of docetaxel in combination with 5-fluorouracil for advanced or recurrent breast cancer. Br J Cancer 77: 1937-1943
2. Caussanel JP, Levi F, Brienza S, Misset JL, Itzhaki M, Adam R, Milano G, Hecquet B, Mathe G (1990) Phase I trial of 5-day continuous venous infusion at circadian rhythm modulated rate compared with constant rate. J Natl Cancer Inst 82: 705-714
3. Lévi F (1997) Chronopharmacology of anticancer gents. In Handbook of Exeperimental Pharmacology: Physiology and Pharmacology of Biological Rhythms-cancer Chemotherapy, Redfern PH, Lemmer B (eds) pp 299-301, Berlin: Springer-Verlag
4. Lortholary A, Delozier T, Monnier A, Bourgeois H, Bougnoux P, Tubiana-Mathieu N, Riffaud JCh, Besson D, Lotz V, Gamelin E (2003) Phase II multicentre study of docetaxel plus 5-fluorouracil in patietnts with anthracycline-pretreated metastatic breast cancer. Br J Cancer 88: 1669-1674
5. Lortholary A, Maillard P, Delva R, Boisdron-Celle M, Perard D, Vernillet L, Besenval M, Gamelin E (2000) Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study. Eur J Cancer 36: 1773-1780
6. Petit T, Aylesworth C, Burris H, Ravdin P, Rodriguez G, Smith L, Peacock N, Smetzer L, Bellet R, Von Hoff DD, Rowinsky EK (1999) A phase I study of docetaxel and 5-fluorouracil in patient with advanced solid malignancies. Ann Oncol 10: 223-229
7. Simon R, Freidlin B, Rubinstein L, Arbuck SG, Collins J, Christian MC (1997) Accelerated titration designs for phase I clinical trials in oncology. J Natl Cancer Inst 89: 1138-1147
8. Smaaland R, Laerum OD, Lote K, Sletvold O, Sothern RB, Bjerknes R (1991) DNA synthesis in the human bone marrow is circadian stage dependent. Blood 77: 2603-2611